618.277.5500

618.277.5500

St. Louis/Madison County ∙ Chicago ∙ New York City

Philanthropy

Philanthropy

Kurowski Shultz Attorneys At Law


Human Rights And A Just Society Symposium 2016

Human Rights and a Just Society Symposium 2016

On October 9– 10, 2016 John Kurowski hosted the Human Rights and a Just Society Symposium for the eleventh time at Nicolaus Copernicus School of Law and Administration in Torun, Poland.    

This year’s symposium titled: “Crimes Against Humanity: Identifying and Bringing Perpetrators to Justice,” featured Ms. Belkis Willie, Senior Iraq researcher at Human Rights Watch; Mr. Thomas Obhof, Assistant to Counsel for the Defense for Dominic Ongwen at the International Criminal Court in the Hague, Netherlands and Dr. Patrycja Grzebyk, Professor of Law at the University of Warsaw.

Over 100 American and Polish students attended the program this year.

Photos from the event can be found here. 

 

JDRF Golf Tournament 2016

JDRF One Walk 2016

It was a beautiful mid-September Sunday when over 200 people gathered to support the Kurowski Shultz annual golf tournament to benefit JDRF.

The participants enjoyed great weather, along with a delicious dinner provided by Andria’s and had a chance to win prizes at a helicopter ball drop.

The firm raised over $35,000 for JDRF.

Photos from the event can be found here.

 

FDA Approves Life-Changing Technology For People Living with Type 1 Diabetes

September 28th, 2016 was an historic day for JDRF and Type 1 Diabetes (T1D) research.  The FDA approved the first hybrid closed-loop insulin delivery system, which many are calling the first “artificial pancreas.”  Kurowski Shultz is proud of its ongoing philanthropic work with JDRF, which has pursued this life-changing breakthrough over the past ten years.

For someone with T1D, a normal day consists of continuously checking her blood sugar or continuous glucose monitor and then correcting the blood glucose level with shots or an insulin pump.  Self-monitoring may involve pricking a finger 20 times a day and self-administering multiple insulin shots.  Essentially, a Type 1 diabetic acts in place of her own pancreas since her actual pancreas does not properly function.  This burden is much greater than the average person could ever imagine.

With the release of the Medtronic MiniMed 670G  artificial pancreas  system, the constant monitoring and adjustment of blood glucose levels is no longer performed by the Type 1 diabetic, but rather the device.  The MiniMed 670G system uses an insulin pump and a continuous glucose monitor to work in connection with one another to adjust the basal insulin rate up or down depending on the diabetic’s blood glucose level.  This automated system removes ”guesswork” and alleviates the heavy burden diabetics face on a daily basis. 

For more information, please see: www.jdrf.org.